Recently, our group demonstrated that adenocarcinoma cells resistant to cisplatin indeed displayed increased expression of the EMT markers N-cadherin and FN and decreased expression of the epithelial marker E-cadherin. This evidence concerns the gene CDH2 and adenocarcinoma.